A NON-INVASIVE, ADAPTIVE DIGITAL THERAPEUTIC SOLUTION FOR POST-TRAUMATIC STRESS DISORDER AND OTHER MENTAL DISORDERS

Informacje na temat projektu

GrayMatters for PTSD - GfP

Identyfikator umowy o grant: 190165249

DOI

10.3030/190165249

Projekt został zamknięty

Data podpisania przez KE 31 Sierpnia 2022

Data rozpoczęcia 1 Września 2022

Data zakończenia 31 Maja 2025

Finansowanie w ramach

• The European Innovation Council (EIC)

Koszt całkowity

€ 3 594 250,00

Wkład UE

€ 2 500 000,00

Koordynowany przez

GRAYMATTERS HEALTH LTD
Israel

Periodic Reporting for period 2 - GrayMatters for PTSD - GfP (A NON-INVASIVE, ADAPTIVE DIGITAL THERAPEUTIC SOLUTION FOR POST-TRAUMATIC STRESS DISORDER AND OTHER MENTAL DISORDERS)

Okres sprawozdawczy: 2023-09-01 do 2025-05-31

Podsumowanie kontekstu i ogólnych celów projektu

Post-traumatic stress disorder (PTSD) is a severe mental disorder, annually affecting 3.2% of the population with global market-size estimated at €7.5B. Current treatments’ success is marginal, costly, with severe side-effects. GrayMatters is the first to introduce a non-invasive therapeutic device harnessing brain plasticity to help PTSD patients control abnormal brain-region activity. Our patented innovation uses proprietary models to fuse fMRI data from amygdala volume with EEG signal to produce specific biomarkers such that patients learn to self-control them using affordable EEG-Neurofeedback device. Initial clinical-trials on stress-resilience & PTSD patients showed significant positive clinical results. The founders have 25+ years experience in commercialization, healthcare & technology with several startups exits/IPOs. The company has won several prestigious awards and grants.
During the proposed project, GrayMatters will implement 4 work packages, in order to reach the project's main objective of launching Prism in the EU market (TRL8): 1) Conducting a large scale clinical KOL study in EU, 2) furthering the company algorithms to support future products delivering better care, 3) preparing for a commercial launch in EU, starting in Germany.

Prace wykonane od początku projektu do końca okresu sprawozdawczego oraz najważniejsze dotychczasowe rezultaty

Work performed is per the plan submitted as reported in the periodic meeting.
On a high level, the key activity, a PTSD patient study was kicked off in 4 sites in Germany and two more sites will join in September 2023

Innowacyjność oraz oczekiwany potencjalny wpływ (w tym dotychczasowe znaczenie społeczno-gospodarcze i szersze implikacje społeczne projektu)

Not applicable at this stage

eic-final-technical-report-4-8-25-page-0002.jpg

eic-final-technical-report-4-8-25-page-0007.jpg

eic-final-technical-report-4-8-25-page-0005.jpg

eic-final-technical-report-4-8-25-page-0003.jpg

eic-final-technical-report-4-8-25-page-0001.jpg

eic-final-technical-report-4-8-25-page-0004.jpg

eic-final-technical-report-4-8-25-page-0006.jpg

eic-final-technical-report-4-8-25-page-0009.jpg

page-8-page-0001-1.jpg